GEN Biotechnology

Published in Association with Mary Ann Liebert
Current Volume: 5 | Current Issue: 2 | ISSN: 27681572 | ESSN: 27681556 | Frequency: Bi Monthly
GEN Biotechnology
Submission Guidelines Browse Content For This Journal
Create Flyer Recommend To Library Get Email Alerts

Select your subscription type:

Individual rates:
Standard pricing for personal use subscriptions.
Subscription start date:

To purchase this journal subscription or a back issue please contact our customer services team with details of the journal, volume or issue you would like.

Library subscriptions

Useful information for subscribing to our journals, including pricing, institutional and consortia subscriptions, information for agents and more.

View Pricing And Subscription Information

Description

The biotech industry has been booming in recent years, setting numerous records, including the annual number of new drugs winning approval, the number of professionals working in biotech, the amount of investment funding, and the cutting-edge technologies fueling further progress and innovation in the industry. New technologies such as CRISPR have sparked an entire sub-industry around genome editing, leading to cures for devastating diseases less than a decade post-development. From next-gen sequencing and organs-on-chips to synthetic biology and spatial biology, the list goes on. This premier peer-reviewed journal from Genetic Engineering & Biotechnology News (GEN) delivers exceptional research breakthroughs, news, and analysis directly impacting biotech. Published bimonthly in print and online with flexible open access options, the journal provides a dynamic forum aimed at unifying both traditional academic audiences and executives and researchers from across the industry.

Description

The biotech industry has been booming in recent years, setting numerous records, including the annual number of new drugs winning approval, the number of professionals working in biotech, the amount of investment funding, and the cutting-edge technologies fueling further progress and innovation in the industry. New technologies such as CRISPR have sparked an entire sub-industry around genome editing, leading to cures for devastating diseases less than a decade post-development. From next-gen sequencing and organs-on-chips to synthetic biology and spatial biology, the list goes on. This premier peer-reviewed journal from Genetic Engineering & Biotechnology News (GEN) delivers exceptional research breakthroughs, news, and analysis directly impacting biotech. Published bimonthly in print and online with flexible open access options, the journal provides a dynamic forum aimed at unifying both traditional academic audiences and executives and researchers from across the industry.
SAGE Publishing Logo

GEN Biotechnology

Published in Association with Mary Ann Liebert

Current Volume: 5 | Current Issue: 2 | ISSN: 27681572 | ESSN: 27681556 | Frequency: Bi Monthly | Submission Guidelines | Get Email Alerts

Subscription Type Format Price
Individual rates Individual, Single Print Issue $83.00
Individual rates Individual, Single Print Issue $83.00
Individual rates Individual Subscription, Combined (Print & E-access) $391.00
Individual rates Individual Subscription, E-access $332.00

The biotech industry has been booming in recent years, setting numerous records, including the annual number of new drugs winning approval, the number of professionals working in biotech, the amount of investment funding, and the cutting-edge technologies fueling further progress and innovation in the industry. New technologies such as CRISPR have sparked an entire sub-industry around genome editing, leading to cures for devastating diseases less than a decade post-development. From next-gen sequencing and organs-on-chips to synthetic biology and spatial biology, the list goes on. This premier peer-reviewed journal from Genetic Engineering & Biotechnology News (GEN) delivers exceptional research breakthroughs, news, and analysis directly impacting biotech. Published bimonthly in print and online with flexible open access options, the journal provides a dynamic forum aimed at unifying both traditional academic audiences and executives and researchers from across the industry.


Recommendations